Overview

Pilot Study of Bioequivalence of Cudafol(R) and Diprivan(R) Administered as Single Intravenous Doses in Healthy Subjects

Status:
Completed
Trial end date:
2016-04-01
Target enrollment:
Participant gender:
Summary
Evaluate pharmacokinetic/pharmacodynamic equivalence and safety and tolerability of single doses of Cudafol(R) and Diprivan(R) in healthy subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Cuda Anesthetics, LLC
Treatments:
Propofol